IDEAYA Biosciences (IDYA) Interest Coverage Ratio (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Interest Coverage Ratio of 0.89 for Q1 2026, down 100.28% sequentially from 315.23 in Q4 2025, and up 89.92% YoY from 0.47 in Q1 2025.
IDEAYA Biosciences (IDYA) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Interest Coverage Ratio for 9 years, with the latest figure at 0.89 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 89.92% year-over-year to 0.89 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.51 (up 96.01% YoY) and the FY2025 annual result came in at 0.81, up 59.1% from the prior year.
- Interest Coverage Ratio slipped to 0.89 in Q1 2026 per IDYA's latest filing, from 315.23 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 315.23 in Q4 2025 and troughed at 1888.79 in Q4 2022.
- A 5-year average of 106.07 and a median of 1.56 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio slumped 121473.87% in 2023, then surged 249.48% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 1888.79 in 2022, then soared by 101.55% to 29.29 in 2023, then slumped by 103.14% to 0.92 in 2024, then surged by 34350.46% to 315.23 in 2025, then slumped by 100.28% to 0.89 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.89, 315.23, and 1.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | -0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.74 |
| Mar 31, 2026 | -0.89 |
| Dec 31, 2025 | 315.23 |
| Sep 30, 2025 | 1.38 |
| Jun 30, 2025 | -1.91 |
| Mar 31, 2025 | -8.86 |
| Sep 30, 2024 | -0.92 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -49.24 |
| Dec 31, 2023 | 29.29 |
| Sep 30, 2023 | -43.37 |
| Jun 30, 2023 | -27.35 |
| Mar 31, 2023 | -17.93 |
| Dec 31, 2022 | -1,888.79 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | -1.54 |
| Mar 31, 2022 | -1.58 |
| Dec 31, 2021 | -9.96 |
| Sep 30, 2021 | -172.25 |
| Jun 30, 2021 | -690.69 |